The monosymptomatic nocturnal enuresis (MNE) is recommended by the International Children's Continence Society (ICCS) to distinguish MNE from non-monosymptomatic nocturnal enuresis (NMNE), which is accompanied by lower urinary tract symptoms (LUTS) such as daytime urinary frequency, urgency, or urinary incontinence. In general, indications for urodynamic studies (UDS) in children include the following: neurogenic bladder, sphincter dysfunction, anorectal malformations, voiding dysfunction including urge syndrome and underactive bladder, vesicoureteral reflux, urinary incontinence, infravesical obstruction, or obstructive uropathy. This study aimed to evaluate the role of UDS in management of refractory monosymptomatic nocturnal enuresis. This prospective study was carried out in Urology . Thirty patients with refractory MNE were enrolled in the study. The included patients with MNE were treated with mono pharmacotherapy (desmopressin) for at least six months without response. Our results show no statistically significant correlation between normal and abnormal filling cystometry.
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The monosymptomatic nocturnal enuresis (MNE) is recommended by the International Children's Continence Society (ICCS) to distinguish MNE from non-monosymptomatic nocturnal enuresis (NMNE), which is accompanied by lower urinary tract symptoms (LUTS) such as daytime urinary frequency, urgency, or urinary incontinence. In general, indications for urodynamic studies (UDS) in children include the following: neurogenic bladder, sphincter dysfunction, anorectal malformations, voiding dysfunction including urge syndrome and underactive bladder, vesicoureteral reflux, urinary incontinence, infravesical obstruction, or obstructive uropathy. This study aimed to evaluate the role of UDS in management of refractory monosymptomatic nocturnal enuresis. This prospective study was carried out in Urology Department, Fayoum University Hospital from December 2017 to August 2018. Thirty patients with refractory MNE were enrolled in the study. The included patients with MNE were treated with mono pharmacotherapy (desmopressin) for at least six months without response. Our results show no statistically significant correlation between normal and abnormal filling cystometry.
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INTRODUCTION:
Nocturnal enuresis (NE) is defined as intermittent incontinence of urine, or bedwetting during sleep, in children more than 5 years of age. (1) . It is a condition that includes a spectrum of disorders with different underlying pathophysiological mechanisms. ( 
AIM OF STUDY:
This study aimed to evaluate the role of UDS in management of refractory monosymptomatic nocturnal enuresis (MNE).
MATERIALS AND METHODS:
A total of 30 refractory monosymptomatic nocturnal enuretic patients (16 boys and 14 girls) with a mean age of 11.83 years (range 8 to 18) were studied. The mean number of bed wetting in patients' group was 15.96 with SD ±2.33 and ranged from 12-28 bed wetting nights per month. Urodynamic studies, including filling cystometry, a postvoid residual (PVR) volume of urine, uroflowmetry, all patients' had prior failed desmopressin therapy.
.
RESUTS:
The filling cystometry of 30 RMNE was normal in 13 patients (43.3%) and abnormal in 17 patients (56.6%) in the form of {detrusor overactivity (DO) in 12 patients (40%) and low bladder compliance in 5 patients (16.6%)}, with p-value (>0.05).
DISCUSSION:
Based on the results of our study, a routine UDS should not be recommended prior to a combination treatment; the combination therapy of anticholinergics with desmopressin could be applied as a first-line treatment for patients with RMNE. Similar to our study, Sehgal et al, (2007), recommended that the monosymptomatic primary enuretics with normal voiding chart may be started on behavioral therapy without subjecting them to urodynamic test. Even in polysymptomatic enuretics, drug therapy may be started empirically. Urodynamic testing may be reserved for polysymptomatic enuretics who show abnormal ultrasound or who fail to respond to first line treatment. While Yucel et al, (2004), reported that the primary nocturnal enuresis (PNE) and NE persisting into adulthood may be associated with abnormal urodynamic findings. Patients may benefit from urodynamic studies, because if the findings are abnormal, they might have the best chance of successful treatment. Also, Ryu et al, (2013), reported that the urodynamic findings were helpful for selecting further treatment strategies for children with RMNE, although in the same study, it was recommend that the urodynamic studies of children with NMNE should not be performed as a routine diagnostic procedure. 
